North America In Vitro Diagnostics Market Size
According to Straits Research analysis, the North America In Vitro Diagnostics Market was valued at USD 29508.14 Million in 2024 and is projected to reach USD 34245.47 Million by 2028, expanding at a CAGR of 4% during the forecast period. The fundamental growth drivers are from the healthcare sector, particularly from infectious disease testing, oncology, and cardiology applications. Other sectors also contributing to demand include chemicals and agriculture, which often utilize such diagnostic tools for various purposes. Technological advancements, including the emergence of point-of-care testing and molecular diagnostics, present growth opportunities. Export potential is also noteworthy, especially to developing regions in need of modern diagnostic tools. As North America continues to innovate in healthcare technology and refine production practices, it is solidly positioning itself to remain a leader in the In Vitro Diagnostics Market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
North America In Vitro Diagnostics Market Highlights
- In 2024, Reagents and Kits emerged as the dominant Product and Services based on market size.
- Reagents and Kits is projected to register the fastest growth, positioning it as the most attractive Product and Services segment over the forecast horizon.
- The global in vitro diagnostics market size saw North America holding a share of 35.56% in 2024.
- United States is forecasted to account for the leading share of the global market by 2028.
- In North America, Canada is forecasted to be the fastest-expanding market, projected to reach USD 24106 Million by 2028.
North America In Vitro Diagnostics Market Revenue Share 2024
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope |
Details |
| Base Year for Study |
2024 |
| Study Period |
2020-2028 |
| Historical Period |
2020-2023 |
| Forecast Period |
2025-2028 |
| Market Size In 2024 |
USD 29508.14 Million |
| Market Size In 2028 |
USD 34245.47 Million |
| Largest segment |
Reagents and Kits |
| Fastest segment |
Reagents and Kits |
| Units |
Revenue in USD Million |
| CAGR |
4% (2025-2028) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
North America In Vitro Diagnostics Market Share By Product and Services
Segmentation Covered
| Segments |
Sub Segments |
| Country |
- United States
- Canada
|
| Product and Services |
- Reagents and Kits
- Instruments
- Data Management Software and Services
|
| Technology |
- Molecular Diagnostics
- Clinical Chemistry
- Immunodiagnostics
- Hematology
- Microbiology
- Others
|
| Application |
- Infectious Diseases
- Oncology
- Cardiac Diseases
- Autoimmune Diseases
- Nephrological Diseases
- Diabetes
- Others
|
| End User |
- Hospitals & Clinics
- Standalone Laboratories
- Home Care Settings
- Others
|
North America In Vitro Diagnostics Market By Country 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
North America In Vitro Diagnostics Market By Product and Services 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
North America In Vitro Diagnostics Market By Technology 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
North America In Vitro Diagnostics Market By Application 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
North America In Vitro Diagnostics Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.